Regeneron Pharmaceuticals, Inc
Primary Climate Goal
This company has not set a company-wide target for an absolute reduction in GHG emissions yet
GHG emissions and Carbon intensity
Scope 1 + 2 GHG emissions (in tons of CO2e) divided by the company's Revenues (in USDm) for the same period
Regeneron Pharmaceuticals, Inc reported Total CO2e Emissions - Market-Based Scope 1 + Scope 2 for the twelve months ending 31 December 2020 at 81 Kt (+0.9/+1.1% y-o-y). At the sime time, carbon intensity plummeted to 9.5 t (-2.7 /-22.1% y-o-y).
Regeneron Pharmaceuticals, Inc's Scope 3 emissions skyrocketed to 769 Kt (
The company has not set a company-wide target for an absolute reduction in GHG emissions yet.